EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Tumor‐educated platelets in cancer diagnostics and prognostics: A critical appraisal and roadmap for clinical translation

Whi-An Kwon iD, Min-Kyung Lee iD, Eunyong Ahn iD, Heeyeon Kim iD, Yong Sang Song iD, Taejin Ahn

International Journal of Cancer · 15.07.2026 · 159 (2) · 302-319

DOI: 10.1002/ijc.70423 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Cancer, online erschienen am 07.03.2026. Verfasst von Whi-An Kwon und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Hanyang University College of Medicine, Myongji Hospital, Goyang, Republic of Korea. Hauptthemen laut MEDLINE: Blood Platelets, Neoplasms, Biomarkers, Tumor. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 136 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tumor‐educated platelets (TEPs) are emerging as a compelling frontier in liquid biopsy, functioning as dynamic, systemic sensors that sequester and process tumor‐derived biomolecules. This interaction imprints an integrated molecular signature of malignancy—spanning the transcriptome, proteome, lipidome, and crucially, the captured genome—within the circulating platelet population. Recent mechanistic evidence suggests that platelets can sequester extracellular DNA, including circulating tumor DNA (ctDNA), and may thereby act as a relatively protected, time‐integrated reservoir that extends the biological persistence of tumor‐derived fragments beyond the short plasma half‐life (tens of minutes to a few hours). This emerging platelet‐sequestered DNA (pDNA) signal complements more established platelet transcriptomic data; to date, most TEP‐based molecular profiling has relied on RNA and has shown promising performance in identifying diverse solid malignancies, including premalignant lesions, and in some settings facilitating localization of the tissue of origin. However, the translation of these findings into clinical‐grade assays is obstructed by substantial hurdles. Pre‐analytical inconsistencies (e.g., leukocyte/erythrocyte contamination, isolation protocol choice) introduce technical noise and pervasive batch effects that compromise reproducibility. These vulnerabilities have been underscored by failed external validations and poor generalizability of discovery‐phase classifiers in independent cohorts and prospective settings. This review critically dissects the factors influencing TEP diagnostic performance and outlines a concrete roadmap for clinical translation. We argue that rigorous standardization—universal standard operating procedures, harmonized pre‐analytics, and quantitative quality‐control metrics—is the sine qua non for implementation, to be followed by large‐scale, prospective validation trials designed to demonstrate clinical utility and by multi‐omics integration to maximize diagnostic yield.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Blood PlateletsNeoplasmsBiomarkers, TumorHumansPrognosisLiquid BiopsyCirculating Tumor DNATranslational Research, Biomedical

Stichwörter der Autor:innen

cancer diagnosisclinical validationearly cancer detectionliquid biopsypan‐cancer screeningplatelet RNAtumor‐educated platelet (TEP)

Substanzen

Biomarkers, TumorCirculating Tumor DNA

Autor:innen und Institutionen

  • Department of Urology, Hanyang University College of Medicine, Myongji Hospital, Goyang, Republic of Korea.
  • Research Institute of Precision Medicine and Geroscience, Myongji Medical Foundation, Goyang, Republic of Korea.
  • Department of Internal Medicine, Hanyang University College of Medicine, Myongji Hospital, Goyang, Republic of Korea.
  • Research Group, Foretell My Health, Pohang, Republic of Korea.
  • Department of Obstetrics and Gynecology, Hanyang University College of Medicine, Myongji Hospital, Goyang, Republic of Korea.
  • Department of Life Science, Handong Global University, Pohang, Republic of Korea.

ORCID-Profile: Whi-An Kwon, Min-Kyung Lee, Eunyong Ahn, Heeyeon Kim, Yong Sang Song

Zitieren

APA

Kwon, W. A., Lee, M. K., Ahn, E., Kim, H., Song, Y. S., & Ahn, T. (2026). Tumor‐educated platelets in cancer diagnostics and prognostics: A critical appraisal and roadmap for clinical translation. International Journal of Cancer, 159(2), 302-319. https://doi.org/10.1002/ijc.70423

Vancouver

Kwon WA, Lee MK, Ahn E, Kim H, Song YS, Ahn T. Tumor‐educated platelets in cancer diagnostics and prognostics: A critical appraisal and roadmap for clinical translation. International Journal of Cancer. 2026;159(2):302-319. doi:10.1002/ijc.70423

BibTeX
@article{Kwon2026,
  author = {Kwon, Whi-An and Lee, Min-Kyung and Ahn, Eunyong and Kim, Heeyeon and Song, Yong Sang and Ahn, Taejin},
  title = {Tumor‐educated platelets in cancer diagnostics and prognostics: A critical appraisal and roadmap for clinical translation},
  journal = {International Journal of Cancer},
  year = {2026},
  volume = {159},
  number = {2},
  pages = {302--319},
  doi = {10.1002/ijc.70423}
}
Kostenlos starten →